President-elect Trump didn’t talk a lot about the Food and Drug Administration while he was on the campaign trail, but judging from what he did say, he will want the FDA to approve new drugs and products much faster.
BioBuzz Workforce Foundation, Inc., a social community organization whose mission is to build a more connected bioscience industry in the region, today announced a partnership with The City of Frederick Department of Economic Development and the Frederick County Chapter of BioBeers Meetup group. This new collaboration will give Frederick companies access to BioBuzz’s BioHive Platform and showcase them as important components within the ecosystem.
WorkSource Montgomery, Inc., the workforce development resource for Montgomery County businesses and career seekers, is collaborating with Montgomery College, which will serve as the lead on a $5.6 million America’s Promise grant. The grant will provide IT and cybersecurity training for students to ensure Montgomery County is better equipped to meet local business needs.
Sean Parker decided to take on cancer by throwing so many deep-rooted basics of research tradition out the window that he very nearly drove away the academics he wanted to attract.
As part of its longstanding commitment to Africa, Johnson & Johnson today announced the launch of the Africa Innovation Challenge, an initiative to support Africa’s vibrant and growing innovation ecosystem and to help develop important and locally sustainable consumer health solutions. The challenge is the latest initiative in the company’s comprehensive approach to advancing health and innovation worldwide. The Johnson & Johnson Family of Companies’ presence in Africa dates back more than 80 years and includes business operations, public health programs and corporate citizenship.
MedImmune, a global biologics research and development arm of AstraZeneca, and Abpro, an integrated life sciences company at the forefront of synthetic biology, announced they have entered into a collaborative agreement to advance the development of a preclinical, novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor (Ang2-VEGF). The agreement is structured as a spin out, benefiting from both companies’ scientific expertise and AbPro’s day-to-day leadership as it oversees the new company, AbMed.
Investigators at the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center (Tufts MC) and Tufts Clinical and Translational Science Institute (CTSI) – a shared resource between Tufts Medical Center and Tufts University School of Medicine (TUSM), together with the Johns Hopkins University (JHU) School of Medicine’s Brain Injury Outcomes (BIOS) Division and the Institute for Clinical and Translational Research (ICTR), won a seven-year, $25 million award from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to form one of only three new national Trial Innovation Centers (TICs) that will provide high-quality design and operational support to investigators conducting multi-center clinical trials.
Joint replacements. Cardiac care. Chemotherapy.
What do those things have to do with the repeal of the Affordable Care Act?
Economists and policymakers think the U.S. may be overpaying for such services, which helps drive up healthcare expenses for everyone. And the health law has a program that includes testing new ways to pay for care — including in those three areas — that might result in better quality and lower costs.
A five-year extension of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs took a big step forward at the end of November.
U.S. Sen. Jeanne Shaheen, D-NH, announced that language she wrote seeking the extension was included in a compromise National Defense Authorization Act, with votes expected soon.
Marriott Hotels in Europe has launched an accelerator program for tech companies to enhance the travel and hospitality experience. Each startup will be given expert guidance and the opportunity to pilot their product. Following a successful test period, Marriott Hotels could potentially offer them an ongoing partnership.